FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2058378421> ?p ?o ?g. }

• W2058378421 endingPage "386" @default.
• W2058378421 startingPage "379" @default.
• W2058378421 abstract "Some patients with inflammatory bowel disease (IBD) never respond or lose their response to a second anti-TNF.To review the efficacy and safety of a third anti-TNF after failure of two previous anti-TNFs. Methods. Bibliographical searches in PubMed for studies evaluating infliximab, adalimumab, or certolizumab as the third anti-TNF in IBD patients whose two previous anti-TNF treatments had failed.Two retrospective studies with a small sample size and limited follow up evaluated the effectiveness of a third anti-TNF patients whose two previous anti-TNFs had failed. The arguments for this switching strategy are as follows: a)favorable--albeit limited--efficacy (in the study by Allez et al., clinical response was observed in 51% of patients at week 20; and in the study by de Silva et al., over 50% of patients remained on the third anti-TNF at 1 year); b)the eventual response to the third anti-TNF is relatively quick; c) no other medical options have been approved for IBD treatment; d)the only alternative options are surgery, compassionate use with non-anti-TNFs, and clinical trials. However, there are also arguments against the prescription of a third anti-TNF: a)lack of experience, since the few available studies are limited by their small sample size; b)the relatively low response in the long term (mainly due to loss of response); c) and finally, and most importantly, the risk of severe adverse events.The delicate balance between pros and cons means the use of a third anti-TNF after failure of two previous agents should be considered only in patients with no other therapeutic options. Decisions should be taken on an individual basis." @default.
• W2058378421 created "2016-06-24" @default.
• W2058378421 creator A5009437472 @default.
• W2058378421 creator A5074679114 @default.
• W2058378421 date "2015-01-30" @default.
• W2058378421 modified "2023-09-23" @default.
• W2058378421 title "Use of a third anti-TNF after failure of two previous anti-TNFs in patients with inflammatory bowel disease: is it worth it?" @default.
• W2058378421 cites W1562235336 @default.
• W2058378421 cites W1968331553 @default.
• W2058378421 cites W1975137320 @default.
• W2058378421 cites W1975218841 @default.
• W2058378421 cites W1982964270 @default.
• W2058378421 cites W1991810959 @default.
• W2058378421 cites W2029110830 @default.
• W2058378421 cites W2030638161 @default.
• W2058378421 cites W2036868912 @default.
• W2058378421 cites W2041750210 @default.
• W2058378421 cites W2053333863 @default.
• W2058378421 cites W2054534978 @default.
• W2058378421 cites W2055851996 @default.
• W2058378421 cites W2069621633 @default.
• W2058378421 cites W2072640801 @default.
• W2058378421 cites W2075090387 @default.
• W2058378421 cites W2080037503 @default.
• W2058378421 cites W2085127303 @default.
• W2058378421 cites W2093504865 @default.
• W2058378421 cites W2102196916 @default.
• W2058378421 cites W2106747769 @default.
• W2058378421 cites W2110367765 @default.
• W2058378421 cites W2112966993 @default.
• W2058378421 cites W2120255351 @default.
• W2058378421 cites W2121609590 @default.
• W2058378421 cites W2122265491 @default.
• W2058378421 cites W2125968436 @default.
• W2058378421 cites W2131632358 @default.
• W2058378421 cites W2133028044 @default.
• W2058378421 cites W2142082253 @default.
• W2058378421 cites W2153438195 @default.
• W2058378421 cites W2155339274 @default.
• W2058378421 cites W2159061752 @default.
• W2058378421 cites W2162766966 @default.
• W2058378421 cites W2165107045 @default.
• W2058378421 cites W2168370388 @default.
• W2058378421 cites W2171341132 @default.
• W2058378421 cites W2313671791 @default.
• W2058378421 doi "https://doi.org/10.3109/00365521.2014.928901" @default.
• W2058378421 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25636030" @default.
• W2058378421 hasPublicationYear "2015" @default.
• W2058378421 type Work @default.
• W2058378421 sameAs 2058378421 @default.
• W2058378421 citedByCount "19" @default.
• W2058378421 countsByYear W20583784212015 @default.
• W2058378421 countsByYear W20583784212016 @default.
• W2058378421 countsByYear W20583784212017 @default.
• W2058378421 countsByYear W20583784212018 @default.
• W2058378421 countsByYear W20583784212019 @default.
• W2058378421 countsByYear W20583784212020 @default.
• W2058378421 countsByYear W20583784212021 @default.
• W2058378421 countsByYear W20583784212023 @default.
• W2058378421 crossrefType "journal-article" @default.
• W2058378421 hasAuthorship W2058378421A5009437472 @default.
• W2058378421 hasAuthorship W2058378421A5074679114 @default.
• W2058378421 hasConcept C126322002 @default.
• W2058378421 hasConcept C141071460 @default.
• W2058378421 hasConcept C177713679 @default.
• W2058378421 hasConcept C197934379 @default.
• W2058378421 hasConcept C2426938 @default.
• W2058378421 hasConcept C2777138892 @default.
• W2058378421 hasConcept C2778260677 @default.
• W2058378421 hasConcept C2779134260 @default.
• W2058378421 hasConcept C2779280984 @default.
• W2058378421 hasConcept C2780132546 @default.
• W2058378421 hasConcept C71924100 @default.
• W2058378421 hasConcept C98274493 @default.
• W2058378421 hasConceptScore W2058378421C126322002 @default.
• W2058378421 hasConceptScore W2058378421C141071460 @default.
• W2058378421 hasConceptScore W2058378421C177713679 @default.
• W2058378421 hasConceptScore W2058378421C197934379 @default.
• W2058378421 hasConceptScore W2058378421C2426938 @default.
• W2058378421 hasConceptScore W2058378421C2777138892 @default.
• W2058378421 hasConceptScore W2058378421C2778260677 @default.
• W2058378421 hasConceptScore W2058378421C2779134260 @default.
• W2058378421 hasConceptScore W2058378421C2779280984 @default.
• W2058378421 hasConceptScore W2058378421C2780132546 @default.
• W2058378421 hasConceptScore W2058378421C71924100 @default.
• W2058378421 hasConceptScore W2058378421C98274493 @default.
• W2058378421 hasIssue "4" @default.
• W2058378421 hasLocation W20583784211 @default.
• W2058378421 hasLocation W20583784212 @default.
• W2058378421 hasOpenAccess W2058378421 @default.
• W2058378421 hasPrimaryLocation W20583784211 @default.
• W2058378421 hasRelatedWork W1588288904 @default.
• W2058378421 hasRelatedWork W1963997208 @default.
• W2058378421 hasRelatedWork W2000908943 @default.
• W2058378421 hasRelatedWork W2085326056 @default.
• W2058378421 hasRelatedWork W2117102124 @default.
• W2058378421 hasRelatedWork W2131408481 @default.
• W2058378421 hasRelatedWork W2186741936 @default.

• next